Clinical Trials for EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor

Find clinical trials for egfr tyrosine kinase inhibitors plus cyclin-dependent kinase 4/6 inhibitor. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Study of Almonertinib Combined With Palbociclib in Patients With Advanced Solid Tumors Harboring KRAS Mutations

NCT ID: NCT06947811

This clinical trial is investigating a new treatment combining two drugs, almonertinib and palbociclib, for patients with advanced solid tumors that have specific mutations in the KRAS gene. The ma...

Recruiting

Phase: PHASE1 Type: interventional Locations: Guangzhou, Guangdong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions